Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACAPULCO study of prasugrel versus high-dose clopidogrel in acute coronary syndrome
2006-002618-37Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of prasugrel and clopidogrel in acute coronary syndrome (ACS) (2 arms), sponsored by Eli Lilly and Company. Started Jul 2006; status: completed.
02
Drugs
prasugrelclopidogrel
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on 2006-002618-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002618-37.